Key Alert: TapImmune Announcements Are a Critical Step in the Company’s Development

LOS ANGELES, CA–(Marketwire – September 9, 2010) – BioMedReports subscribers have been alerted that TapImmune Inc. ( OTCBB : TPIV ) is starting to pick up momentum as a bottom-up play which features innovative therapeutics and vaccines in the areas of oncology and infectious disease. Their TAP technology deals directly with the cellular arm of the immune system is critical in protecting us …